REBECCA LEGGETT: Open Payments
NPI 1841410198 · WHITE CITY, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$482 in 21 payments from 6 companies in 2025. Trend: 2023 $504 · 2024 $685 · 2025 $482
Food & beverage: $381Education: $101
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $178 |
| Otsuka America Pharmaceutical, Inc. | 9 | $174 |
| Astellas Pharma US Inc | 1 | $85 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Novo Nordisk Inc | 1 | $15 |
Products named: REXULTI, CREON, VRAYLAR, BREZTRI, TRELEGY ELLIPTA, Wegovy, MAVYRET.
Industry payments across OR — which companies pay providers there.
